KPNB1 and central nervous system cancer: Further analysis using the CGGA database found that KPNB1 levels were positively associated with the WHO grade of the glioma, with higher KPNB1 expression in WHO IV gliomas than those graded as WHO II or WHO III (Fig. 1B).